LQDALiquidia Corporation

$3B

Q3 2020 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$0

Gross Profit

$0

Operating Income

-$15M

Net Income

-$15M

EPS (Diluted)

$-0.40

QoQ Revenue Growth

NaN%

Cash Flow

Operating Cash Flow

-$13M

Free Cash Flow

-$13M

Stock-Based Comp.

$1M

Balance Sheet

Total Assets

$91M

Total Liabilities

$26M

Stockholders' Equity

$65M

Cash & Equivalents

$80M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$0	$0	—
Gross Profit	$0	$0	—
Operating Income	-$15M	-$13M	-11.2%
Net Income	-$15M	-$13M	-11.5%

LQDA Q3 2020 Earnings — Liquidia Corporation Revenue & Financial Results | Market Cap Arena